Could this be the UK's most expensive medicine?

The NHS could be forking out £82 million per year for a new drug, that can help people with atypical Haemolytic Uraemic Syndrome to live longer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.